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Abstract: Low stability of transgenes and high variability of their expression levels among the obtained
transformants are still pending challenges in the nuclear genetic transformation of microalgae. We have
generated a new multicistronic microalgal expression plasmid, called Phyco69, to make easier the
large phenotypic screening usually necessary for the selection of high-expression stable clones. This
plasmid contains a polylinker region (PLK) where any gene of interest (GOI) can be inserted and
get linked, through a short viral self-cleaving peptide to the amino terminus of the aminoglycoside
3′-phosphotransferase (APHVIII) from Streptomyces rimosus, which confers resistance to the antibiotic
paromomycin. The plasmid has been validated by expressing a second antibiotic resistance marker,
the ShBLE gene, which confers resistance to phleomycin. It has been shown, by RT-PCR and by
phenotypic studies, that the fusion of the GOI to the selective marker gene APHVIII provides a simple
method to screen and select the transformants with the highest level of expression of both the APHVIII
gene and the GOI among the obtained transformants. Immunodetection studies have shown that the
multicistronic transcript generated from Phyco69 is correctly processed, producing independent gene
products from a common promoter.
Keywords: 2A; microalgae transformation; paromomycin; multicistronic transcript
1. Introduction
Microalgae are a heterogeneous group of photosynthetic microorganisms highly attractive for the
production of many different interesting metabolites. However, the high cost of microalgal culture
systems and the low productivity of many of these compounds have hampered their commercial
applications. Currently, only high added value compounds, such as pharmaceuticals, cosmetics,
or nutraceuticals, are produced from microalgae at industrial scale [1]. In other fields, competition with
synthetic products or with those obtained from other sources makes the production of microalgal-based
compounds non-viable from the economical point of view [2–6]. As a consequence, more attention
is being paid to the genetic engineering of microalgae as a potential tool to achieve economically
feasible production of bulk materials and to enhance the productivity of the high added value
ones [7–9]. Although in recent years, an increasing number of microalgal species have been successfully
transformed and important goals have been accomplished, the genetic transformation of microalgae
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has still important pending challenges. Both, the low stability of the transgenes and the high variability
of their expression levels among the obtained transformants, make necessary large screenings to select
high-expression stable clones [10–12]. In fact, low nuclear expression of transgenes in microalgae has
hampered the efficient and stable engineering of metabolic pathways and has limited the use of these
microorganisms for the commercial production of recombinant proteins. Until now, the expression
of heterologous genes in chloroplasts is the only approach that has led to protein accumulation at
economically viable levels [8,13,14]. However, nuclear expression provides the recombinant proteins
with desirable characteristics, which cannot be acquired if they are expressed in the chloroplasts, such
as post-translational modifications or targeting of the protein products to different organelles [15,16].
The nuclear transformation of microalgae takes place mainly by random integration. This means
that transgenes are randomly inserted in the genome, and consequently their expression level will
largely depend on a series of factors such as the insertion site, the environment genome surrounding
of the inserted transgene, the number of copies inserted or differences with the codon usage of the
host [10]. Random insertion followed by an exhaustive phenotypic screening of a large number of
clones continues being the most usual approach for the selection of transformants with good levels
of expression and stability [17,18]. However, different imaginative solutions have been proposed to
overcome these time-consuming screenings and to get high expression of the transgenes. Improvement
of promoters and regulatory regions (HSP70A, RbcS2 intron) [19–23], inclusion of additional introns [24]
or adaptation of the codon usage of the transgene to that of the host microalga [25–27] have shown
to improve expression and stability of marker genes such as GFP and luciferase in Chlamydomonas
reinhardtii. We have previously demonstrated that fusing the gene of interest without promoter to an
antibiotic resistance gene can lead to high expression [28]. Neupert and coworkers described high
accumulation of proteins encoded by nuclear transgenes (about 0.2% of total soluble proteins) by UV
induced mutagenesis of the obtained transformants followed by screening to isolate defective mutants
in transgene suppression mechanisms [29]. A similar strategy was proposed by Kong and coworkers,
who studied expression of proteins in a mutant of Chlamydomonas affected in a methyltransferase
involved in transcriptional gene silencing [30].
A further improvement has been achieved by including the self-cleaving 2A peptide derived from
the foot-and-mouth disease virus (FMDV-2A) between the GOI and the selectable gene. This peptide
is processed in the eukaryotic ribosome due to a ribosomal skip between Gly23 and Pro24 amino
acids [31]. The use of this small peptide for the co-expression of several genes under the same promoter
and then, thanks to its co-translational cleavage ability obtain the independent gene products, has been
applied to a wide range of eukaryotic systems, such as mammalian cells [32], fungi [33] and plants [34].
This strategy has also been shown to work in microalgae [30,35]. Mayfield and coworkers described the
fusion of the bleomycin resistance gene (ShBLE) with the xylanase gene of Trichoderma reesei [35] and
several fluorescent marker genes [16] through the small self-cleaving 2A peptide and demonstrated the
obtaining of high yields of the independent proteins from a common transcript [36]. However, the high
mutagenic effect of bleomycin and related antibiotics [37,38] and the need of extending the number
of selective agents available have led us to propose an alternative gene fusion strategy to improve
transgenes expression in microalgae based on the APHVIII resistance gene. This gene encodes the
enzyme aminoglycoside 3′-phosphotransferase from Streptomyces rimosus and confers resistance to
the antibiotic paromomycin [39]. We have generated different multicistronic expression plasmids in
which the polylinker region is fused through the short self-cleaving 2A peptide to both termini of the
selective APHVIII gene and evaluated their efficiency for the genetic transformation of the microalgae
Chlamydomonas reinhardtii. Moreover, we have demonstrated that screening of the transformants with
increasing amounts of the antibiotic paromomycin provides a simple method for the selection of clones
with the highest level of expression of APHVIII gene, and consequently of the gene of interest, among
the obtained transformants.
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2. Results and Discussion
2.1. Construction and Transformation Efficiency of Several Multicistronic APHVIII-based Fusion Plasmids
Three different plasmids containing the paromomycin resistance gene, APHVIII, fused to a
polylinker region through the foot-and-mouth disease virus self-cleaving 2A peptide sequence
(FMDV-2A) have been constructed. In the three plasmids the APHVIII gene is placed under the
control of the heat shock protein 70A/ribulose-1,5-bisphosphate carboxylase/oxygenase small subunit 2
tandem chimeric promoter (HSP70A-RBCS2) and terminated by the 3′RBCS2 untranslated region [19].
In addition, in the three plasmids the first intron of the Rubisco small subunit, which has shown to
increase transformation efficiencies, has been included after the promoters and immediately before the
corresponding marker gene or polylinker region, as detailed in Figure 1A. Plasmid pSI103 described
by Sizova was used as a control plasmid [40]. The first construct encodes for the APHVIII protein
linked through its carboxyl end (C-end) to the FMDV-2A peptide, which is followed by the polylinker
region. The resulting plasmid was called PhycoC67. In the second construct, the C-end of the
APHVIII sequence was linked to the self-cleaving 2A peptide through a flexible peptide sequence
(GASGQGASGADIGASGQGASDA), this plasmid was denoted as PhycoC67FL. In the third construct,
the same elements used for plasmid PhycoC67 were placed in inverse order, so that the PLK region
followed by the self-cleaving 2A peptide is fused to the amino-end (N-end) of the APHVIII gene,
this last plasmid was named Phyco69. The detailed schematic diagrams of this construct are shown in
Figure 1A, and the sequences of the proteins obtained from their expression are shown in Figure 1B.
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The 2A peptide allows that the chimeric transcripts generated from these constructions are
processed upon translation in the ribosome, generating independent gene products, the APHVIII,
and the one corresponding to the gene inserted in the polylinker region. The ribosomal skip takes place
between the two final C-terminal amino acids of the 2A peptide, glycine, and proline, and consequently
an extra peptidic sequence will be added to the C-end of the APHVIII when it is situated upstream
the 2A peptide, as it happens in plasmids PhycoC67 or PhycoC67FL. However, in the case of plasmid
Phyco69, the APHVIII gene is located downstream the 2A peptide, and consequently, a single proline
amino acid will be added to its N-terminal.
The model microalga Chlamydomonas reinhardtii was transformed by the glass beads agitation
method with the three plasmids, PhycoC67, PhycoC67FL, and Phyco69, as described in Section 3.3
Materials and Methods. The efficiency of these transformations was compared with that obtained with
the control plasmid pSI103 [40]. As shown in Figure 1C, the transformation efficiency of PhycoC67
was extremely low, showing that even small peptides such as the FMDV-2A self-cleaving peptide
interfere with the functionality of the aminoglycoside 3’-phosphotransferase if these are bound to its
carboxyl terminal end. Protein linkers imitate the linkers naturally occurring in multi-domain proteins
and usually avoid misfolding or impaired bioactivity of the fusion proteins, however, the flexible
peptide used in PhycoC67FL did not offer any appreciable advantage. By contrast, Phyco69 plasmid,
in which the FMDV-2A is linked to the amino terminal of the APHVIII protein, provided the highest
transformation efficiencies with around 420 transformants µg−1 of DNA. This is three-fold the mean
transformation efficiency obtained with the control pSI103 plasmid designed by Sizova [39], which is
about 130 transformants µg−1 of DNA (Table 1).
Table 1. Transformation efficiency of Chlamydomonas reinhardtii with increasing quantities of the
indicated plasmids. All values are the average of between three and five repetitions ± SD. The mean
number of transformants µg−1 of DNA is also indicated.
Plasmid 200 ng 500 ng 1 µg 2 µg Transformants µg−1 DNA
Phyco69 98 ± 22 215 ± 38 380 ± 58 820 ± 70 427
pSI103 28 ± 12 60 ± 21 140 ± 32 250 ± 45 131
PhycoC67 0 5 ± 2 7 ± 4 18 ± 6 6.5
PhycoC67FL 0 8 ± 4 12 ± 7 3.5
We concluded that the fusion of peptides through the amino-end does not affect the functionality
of the aminoglycoside 3’-phosphotransferase, however, the fusion to the carboxyl-end of even small
peptides such as the 2A peptide, interferes with its function. Although there is certain variability in
the number of transformants obtained with these plasmids, we systematically obtained much higher
transformation efficiencies with the plasmid Phyco69, around three times higher than with the control
plasmid pSI103. After a careful analysis, we found that the increase in the transformation efficiency
with the new Phyco69 plasmid is due to the fact that in Phyco69 the APHVIII gene is in the same reading
frame than the initiation codon, which is immediately before the RbcS2 intron. Whereas in pSI103
the initiation codon does not match with the open reading frame of the APHVIII protein. Detailed
sequences of the products obtained after the elimination of the RbcS2 intron in pSI103 and Phyco69 are
shown in Figure A1. In pSI103 a mix of transcripts with different reading frames must be produced
and the selective pressure of the antibiotic makes possible that those transformants in which the correct
APHVIII protein is synthesized survive. The detailed map of the Phyco69 plasmid, the one chosen for
further studies, can be found on PhycoGenetics website (http://phycogenetics.com/products/).
This plasmid allows higher transformation efficiencies than other plasmids with the same
promoter. In addition, selection based on the antibiotic paromomycin is fast and clean, without
spontaneous resistant clones or mutagenic effects [10]. The placement of the polyclonal region
upstream the aminoglycoside 3’-phosphotransferase solves the problems generated when additional
peptide sequences are fused to the carboxyl-end of this protein. In this case, the desired genes have to
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be deprived of their stop codon before being cloned in the Phyco69 plasmid to allow the transcription
of the whole transcription unit. However, this apparent disadvantage ensures that all the transformants
surviving in the presence of paromomycin are also expressing the GOI, which is placed upstream
the APHVIII. If the GOI was placed downstream the resistance gene, some of the transformants
could contain truncated transcripts in which the GOI is not transcribed. Since nuclear DNA insertion
in microalgae is usually accompanied of deletions or truncations both in the genomic and insert
DNA [41], ensuring the expression of the target gene by placing it upstream the selectable marker can
be very useful.
Generation of fusion recombinant proteins or even the addition of short protein sequences to
the ends of a protein can interfere with its structure and function. The possible influence of the
remnants from the short 2A peptide in each protein of interest has to be investigated for each case.
In the case of the APHVIII protein, we have demonstrated that the addition of even a few amino
acidic units to its carboxylic-end affects its functionality. The few cases found in the literature, which
describe the fusion of APHVIII to other proteins, involve its link through the amino end [18,40].
The structure of the APHVIII protein has been determined by X-ray crystallography [42] and is
available in the protein data bank (PDB 4H05). APHVIII is a dimeric protein, each monomer consists of
two lobes, the N-terminal domain with a β-strand motif of five anti-parallel sheets and two α-helices,
and the catalytic C-domain with six α-helices. The three-dimensional structure of the APHVIII protein
confirmed the conclusions previously established on the basis of sequence comparisons and point
mutations, that pointed the final amino acid Phe267, as one of the conserved residues essential for the
direct interaction with the aminoglycoside substrate [40]. This can explain why plasmid PhycoC67,
in which the polylinker region is downstream the APHVIII sequence fused to its carboxylic-end,
shows such a low transformation efficiency.
2.2. Phyco69 Enables the Selection of Transformants with High Expression Levels of the Gene of Interest
Our hypothesis is that by subjecting the transformants obtained with the plasmid Phyco69 to
screening with increasing concentrations of the antibiotic paromomycin, it will be possible to select those
clones which accumulate high concentrations of the aminoglycoside 3′-phosphotransferase protein
and consequently of our protein of interest. Furthermore, both the protein of interest and the protein
conferring resistance to the antibiotic are processed from the same multicistronic transcript, and if the
transformants are maintained under selective conditions, the synthesis of the protein of interest is
guaranteed to enhance in this way the stability of the transgenes. To validate this hypothesis, we cloned
the antibiotic-resistance ShBLE gene, which confers resistance to antibiotics of the bleomycin family in
the polylinker region of Phyco69 plasmid. The ShBLE gene with the first intron of RbcS2, which has
shown to increase stability and transformation efficiency of the ShBLE gene [19,43], was PCR-amplified
and inserted in the polylinker of Phyco69. The resulting plasmid, Phyco69BLE was used for the
genetic transformation of Chlamydomonas. The layout of the experiment is depicted in Figure 2. Initial
transformants selected in the presence of 30 µg·mL−1 of paromomycin appeared after four or five
days and were screened with increasing concentrations of paromomycin (300, 400, 500 µg·mL−1) and
phleomycin (0.5, 1 µg mL−1). One hundred transformants were cultured in 2 mL of liquid TAP medium
with paromomycin 15 µg mL−1 during 48 h. The cellular density of all the cultures was then adjusted
to the same value, and a drop of each transformant culture was symmetrically spotted in an ordered
array on TAP agar plates supplemented with 300, 400 or 500 µg·mL−1 of paromomycin or with 0.5 or
1 µg mL−1 of phleomycin, where they were grown for several days. All experiments were carried out
in triplicate.
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Figure 2. Schematic diagram of the selective strategy used to choose Chlamydomonas transformants
with high levels of expression of genes APHVIII and ShBLE.
The average survival rate after transference to 500 µg mL−1 of paromomycin was 55%, very similar
to the average survival rate in the presence of 1 µg mL−1 phleomycin, which was about 57%
(Figure A2). We observed that practically all the transformed clones able to grow in the presence of
high concentrations of paromomycin (500 µg mL−1) are also able to grow vigorously with phleomycin
(1 µg mL−1). This indicates that these clones have high levels of expression of both APHVIII and
ShBLE genes because it has been previously reported that high levels of the bleomycin binding protein,
encoded by the ShBLE gene, are necessary to show a phleomycin resistance phenotype [35,43].
To confirm this, we studied the expression levels of APHVIII and ShBLE in a series of transformed
clones obtained with the Phyco69BLE plasmid (Figure 3A). The correct simultaneous insertion of both,
APHVIII and ShBLE genes, in the genome of the selected clones, was checked by PCR with specific
primers that anneal at the end of the ShBLE gene and at the beginning of the APHVIII gene. All the
clones checked had incorporated both genes correctly in their genomes (Figure 3C).
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On the one hand, we studied three PARR, BLER-transformants that could grow in 30 µg mL−1
paromomycin but were not able to survive neither in paromomycin 500 µg mL−1 nor in phleomycin
1 µg mL−1 (#14, #25, #34). On the other hand, we selected three transformants able to grow vigorously
both in paromomycin 500 µg mL−1 and in phleomycin 1 µg mL−1 (#4, #7, #22). The transcripts levels
corresponding to both genes were determined by real-time PCR using specific primers for each gene
and the ubiquitin ligase gene (UBQL) as housekeeping gene (Figure 3D).
As shown in Figure 3D, the APHVIII and ShBLE transcript levels in the transformants which
tolerate high concentrations of paromomycin (500 µg mL−1) are between five and eight times the
transcript levels found in the transformants isolated in 30 µg mL−1 paromomycin but unable to survive
at higher concentrations of paromomycin (Figure 3B). This confirms that the selective pressure with
paromomycin provides a fast method for the selection of the transformants with the highest levels of
expression of the desired gene.
The self-cleaving peptide FMDV-2A has been successfully used in several eukaryotic systems [34].
Mayfield and coworkers have demonstrated in the microalga Chlamydomonas reinhardtii, that the
FMDV-2A approach can be successfully used to fuse the desired gene to the ShBLE gene, which
provides resistance to antibiotics of the bleomycin family [36]. The mechanism of action of BLE, which
relies on antibiotic sequestration rather than enzymatic inactivation, ensures that the transformants
surviving in these antibiotics have high levels of expression [43]. However, it is desirable to extend the
palette of selectable markers available to be used with the FMDV-2A system because the selection of
some microalgae must be done with other antibiotics to which they are more susceptible. In addition,
bleomycin is highly mutagenic [37,44], and this is an undesirable effect, especially when an unequivocal
relation between the obtained phenotype and the expressed gene must be established.
2.3. Phyco69 Enables the Simultaneous Expression of Two Genes, Which are Efficiently Processed Generating
Independent Proteins
Although the utility of the 2A peptide to generate independent mature proteins from a common
RNA transcript has been well established, the cleavage efficiency of the 2A sequences can be influenced
by the C-terminal of the protein upstream the 2A. In the present work, immunodetection studies
using anti-APHVIII antibodies on the transformants obtained with Phyco69BLE plasmid showed a
29.2 KDa-band, which corresponds to the size of the APHVIII protein, while no band is detected at
42.9 KDa, the size expected for the fusion Ble-2A-APHVIII protein product (Figure 4, Figure A3).
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Figure 4. I munoblot analysis showing the APHVIII protein product from C. reinhardtii cells
transformed with the plasmid Phyco69BLE. Total soluble cell protein extracts (60 µg) of three
Chlamydomonas transformants (#4, #7, #22) and one control untransformed Chlamydomonas culture
(C-) were fractionated with SDS-PAGE, transferred to a PVDF membrane and probed with rabbit
anti-APHVIII polyclonal antibodies and alkaline phosphatase-conjugated goat anti-rabbit IgG,
as indicated in materials and methods. MW lane: Protein molecular weight markers.
This demonstrates that the multicistronic transcript is correctly processed generating independent
proteins and no detectable fusion product. The 2A system has previously shown to improve expression
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of the squalene synthase from Botryococcus braunii [30] and several selectable marker proteins in
Chlamydomonas [35,45]. In all these cases, the efficient generation of two independent protein products
through the 2A peptide has been reported. Furthermore, this auto-cleaving peptide has allowed the
successful expression of four independent proteins from a single vector in Chlamydomonas [18] and up to
six different genes in human cell lines [46]. Other viral sequences similar to the foot-and-mouth disease
2A have been reported to undergo similar translational self-cleaving with different efficiencies [47].
Moreover, some authors have even reported the efficient expression of two genes from a single
bicistronic mRNA by simply joining the two genes of interest by a short stretch of unstructured junction
sequences, without the need of viral sequences [48]. Although further insights are necessary to clarify
the precise mechanism of the 2A induced ribosome skip, multicistronic plasmids have important
advantages over co-transformation approaches in which the selective marker and the gene of interest
are in independent expression cassettes and usually result in low percentages of genome insertion of
the desired gene.
3. Materials and Methods
3.1. Strains and Culture Conditions
Chlamydomonas reinhardtii 704 strain (Cw15, Arg7+, mt+) was kindly donated by Dr. Roland
Loppes (University of Liège, Sart Tilman, Belgium) [49], and cultured photomixotrophically in liquid or
agar solidified Tris-acetate phosphate (TAP) medium under continuous white light irradiation (50 µE
m−2 s−1 photosynthetically active radiation) at 25 ◦C in a culture chamber. The DH5α Escherichia coli
strain, used for in vivo amplification of DNA, was cultured in an LB medium.
3.2. Plasmids Constructions
A synthetic DNA fragment (Genscript, Co, Piscataway, NJ, USA) flanked by the RsrII and the
BamHI recognition sequences and consisting of 170 final nucleotides of the APHVIII gene without
the stop codon, followed by the FMDV-2A, the 6 histidines encoding sequences and an artificial
polylinker sequence, was cloned between the RsrII / BamHI sites of the plasmid pSI104 to obtain
plasmid PhycoC67. Plasmid pSI104 [50] is a modification of plasmid pS103 [40] obtained from the
Chlamydomonas Resource Center US (https://www.Chlamycollection.org). APHVIII encodes the enzyme
aminoglycoside 3′-phosphotransferase Streptomyces rimosus and confers resistance to the antibiotic
paromomycin. The FMDV-2A is a small self-cleaving peptide derived from the foot-and-mouth disease
virus. Plasmid PhycoC67FL was prepared by including a synthetic DNA sequence that encodes
the flexible peptide GASGQGASGADIGASGQGASDA between the APHVIII and the FMDV-2A
sequences of plasmid PhycoC67. Plasmid Phyco69 available from PhycoGenetics SL., (Huelva, Spain)
(http://www.phycogenetics.com) was constructed by including in front of the APHVIII gene of plasmid
pSI104 a synthetic DNA fragment (Genscript, Co) consisting of the final nucleotides of the 5′ regulatory
region of RbcS2, followed by the 6 histidines, the FMDV-2A encoding sequences, and an artificial
polylinker. This DNA fragment was inserted between the HindIII and BstBI restriction sites of pSI104
(Figure 1). Phyco69BLE plasmid was obtained by inserting between the ClaI and SpeI restriction sites
of plasmid Phyco69 a stop codon-less version of Streptoalloteichus hindustanus BLE gene. This version
of the ShBLE gene contains the first intron of the RBCS2 gene and confers resistance to bleomycin and
related glycopeptide antibiotics, such as zeocin and phleomycin, upon binding to them.
3.3. Chlamydomonas Nuclear Transformation
The nuclear transformation of C. reinhardtii was carried out using the glass beads method of
Kindle [51] with minor modifications. Chlamydomonas cultures were grown to a cell density of about
107 cells mL−1, afterwards they were centrifugated, spinned down, and resuspended to get a final 100
fold concentrated cell suspension. 0.3 g of sterile glass beads (0.4–0.6 mm Ø) were added to 0.6 mL of
concentrated cell suspension, 0.2 mL of 20% polyethylene glycol (MW8000), and the indicated quantity
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of the desired plasmid. This mixture was agitated during 10 s, and then cells were resuspended in
50 mL of fresh TAP medium and left in dim light overnight. After this incubation, cells were spread
onto the selective solid medium carrying 30 µg mL−1 of paromomycin. Transformed colonies were
visible after four or five days.
3.4. Real Time PCR
qPCR experiments were performed on the Mx3000P Multiplex Quantitative PCR System (Agilent
Technology, La Jolla, CA, USA) using as template 1 µL of the cDNA, synthesized from total RNA
according to the Invitrogen SuperScript II RNase-reverse transcriptase manual (Life Technologies
Corporation, Carlsbad, CA, USA) and Brilliant SYBR® Green QPCR Master Mix (Agilent Technologies,
La Jolla, CA, USA). Cycling conditions were: 10 min at 95 ◦C for activation of the Hot start Taq
polymerase and 40 cycles for the melting (30 s at 95 ◦C), annealing (30 s at 61 ◦C), and extension (30 s at
72 ◦C). Each qPCR measurement was carried out in triplicate using specific primers for either ShBLE
or APHVIII (Table A1). The UBC8 gene, encoding a ubiquitin ligase polypeptide (XM_001697453),
whose expression was previously shown to be constitutive under the different conditions used [52,53]
and was used as a housekeeping gene to normalize mRNA abundance. 2−∆∆CT approach was used to
calculate fold change relative to the expression level of a reference clone, which was chosen among the
transformants which showed the lowest values [54].
3.5. Western Blot
For Western blot analysis, proteins, separated by denaturing SDS-PAGE as previously
described [55], were transferred from acrylamide gel onto a polyvinylidene difluoride membrane
(PVDF) using the Mini Trans-Blot system (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s
instructions. PVDF membrane was washed with TBS and blocked overnight with 2.5% nonfat-dry
milk containing 0.2% Tween 20. Immunodetection of APHVIIII in C. reinhardtii crude extracts was
performed using anti-APHVIII protein antibodies, raised in rabbit immunized with the recombinant
purified APHVIII protein (500 mg), as primary antibodies at 1:8000 dilution in TBS (0.5% nonfat-dry
milk, 0.2% Tween 20) and alkaline phosphatase (AP)-conjugated goat-anti-rabbit IgG (SIGMA) at
1:20,000 dilution as secondary antibody.
4. Conclusions
Great efforts are being made to increase the level of expression of heterologous genes in the
microalgal nucleus. The fusion of the genes of interest through the self-cleaving 2A peptide to a
selectable marker is a good strategy for expression of foreign genes in microalgae, which to date
has never been implemented using the versatile and efficient paromomycin resistant gene, APHVIII.
Here we demonstrate the suitability of a plasmid containing this antibiotic-resistant marker to express
independent proteins linked through the FMDV-2A peptide, as long as they are fused through its
N-terminal. Paromomycin is a stable and reliable antibiotic which lacks the mutagenic effects of
other antibiotics, such as bleomycin or related antibiotics, and allows quick isolation of transformants
without spontaneous resistance. Plasmid Phyco69, designed to contain any gene of interest linked
through the 2A fragment upstream of the APHVIII gene has been validated using the ShBLE, which
encodes the bleomycin resistant protein as a gene of interest. Immunodetection studies showed
that the multicistronic transcript generated from Phyco69 plasmid is correctly processed, generating
independent gene products. Phenotypic studies and RT-PCR analysis have shown that screening the
transformants with increasing amounts of the antibiotic paromomycin provides a simple method for
the selection of clones with the highest level of expression of APHVIII gene, and consequently of
the gene of interest. This plasmid can be used to express different exogenous proteins of interest or
overexpress homologous proteins in this and other related microalgae.
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